Statement Of Financial Position [Abstract]

AUGA group - Filing #2157174

Concept	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Property, plant and equipment	90 816 EUR	—	—	—	—	—	—	—	—	—	93 711 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Right-of-use assets	48 664 EUR	—	—	—	—	—	—	—	—	—	48 322 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Investments accounted for using equity method	57,000 EUR	—	—	—	—	—	—	—	—	—	57,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Non-current biological assets	10 686 EUR	—	—	—	—	—	—	—	—	—	10 515 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Trade and other non-current receivables	536,000 EUR	—	—	—	—	—	—	—	—	—	518,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax assets	2 292 EUR	—	—	—	—	—	—	—	—	—	2 919 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Non-current assets	159 982 EUR	—	—	—	—	—	—	—	—	—	162 584 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Current assets [abstract]
Current inventories	28 663 EUR	—	—	—	—	—	—	—	—	—	35 241 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Trade and other current receivables	10 118 EUR	—	—	—	—	—	—	—	—	—	7 832 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Current biological assets	23 073 EUR	—	—	—	—	—	—	—	—	—	19 883 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	3 455 EUR	—	—	—	—	—	—	—	—	—	3 337 EUR	—	—	—	—	—	—	—	—	—	—	2 446 EUR	—	—	—	—	—
Current assets	68 699 EUR	—	—	—	—	—	—	—	—	—	68 834 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Assets	228 681 EUR	—	—	—	—	—	—	—	—	—	231 418 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	67 203 EUR	—	—	—	—	—	—	—	—	—	66 617 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Retained earnings	33 060 EUR	—	—	—	—	—	—	—	—	—	14 654 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Share premium	6 707 EUR	—	—	—	—	—	—	—	—	—	6 707 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity attributable to owners of parent	61 397 EUR	—	—	—	—	—	—	—	—	—	77 105 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Non-controlling interests	394,000 EUR	—	—	—	—	—	—	—	—	—	428,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity	61 791 EUR	33 060 EUR	15 613 EUR	394,000 EUR	6 707 EUR	67 203 EUR	61 397 EUR	2 893 EUR	2 041 EUR	2 041 EUR	77 533 EUR	13 565 EUR	428,000 EUR	6 707 EUR	2 829 EUR	14 654 EUR	66 617 EUR	77 105 EUR	2 041 EUR	10 251 EUR	9 328 EUR	78 980 EUR	78 623 EUR	6 707 EUR	3 002 EUR	358,000 EUR	65 951 EUR
Liabilities [abstract]
Non-current liabilities [abstract]
Deferred tax liabilities	1 805 EUR	—	—	—	—	—	—	—	—	—	1 863 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Non-current liabilities	61 668 EUR	—	—	—	—	—	—	—	—	—	83 236 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Current liabilities [abstract]
Trade and other current payables	27 721 EUR	—	—	—	—	—	—	—	—	—	25 352 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Current liabilities	105 222 EUR	—	—	—	—	—	—	—	—	—	70 649 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Liabilities	166 890 EUR	—	—	—	—	—	—	—	—	—	153 885 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities	228 681 EUR	—	—	—	—	—	—	—	—	—	231 418 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—